Improved motor function in dko mice by intravenous transplantation of bone marrow-derived mesenchymal stromal cells

Cytotherapy

Volumn 13, Issue 1, 2011, Pages 69-77

  Li, Zhong ^a   Liu, Hong Ying ^a   Lei, Qing Feng ^a   Zhang, Cheng ^a   Li, Shu Nong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Mesenchymal stromal cell; Transplant; Utrophin

Indexed keywords

DYSTROPHIN; UTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BONE MARROW; CAUDA EQUINA; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; LIFESPAN; LOCOMOTION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOLEMMA; SRY GENE; TRACTION THERAPY; Y CHROMOSOME;

EID: 78650396032     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.510502     Document Type: Article

References (32)

1. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509-17.
2. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 1986;323:646-50.
3. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919-28.
4. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, et al. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988;333:466-9.
5. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, et al. Utrophin-dystrophin-defi cient mice as a model for Duchenne muscular dystrophy. Cell. 1997; 90:717-27.
6. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 1997;90:729-38.
7. Bulfi eld G, Siller WG, Wight PA, Moore KJ. X chromosomelinked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 1984;81:1189-92.
8. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989;244:1578-80.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7.
10. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000;28:875-84.
11. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259-64.
12. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19:180-92.
13. Bhagavati S. Stem cell based therapy for skeletal muscle diseases. Curr Stem Cell Res Ther. 2008;3:219-28.
14. Blau HM. Cell therapies for muscular dystrophy. N Engl J Med. 2008;359:1403-5.
15. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279: 1528-30.
16. Bittner RE, Schöfer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, et al. Recruitment of bone-marrowderived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391-6.
17. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-4.
18. Fukada S, Miyagoe-Suzuki Y, Tsukihara H, Yuasa K, Higuchi S, Ono S, et al. Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fl uorescent protein-gene transgenic mice. J Cell Sci. 2002;115:1285-93.
19. Corti S, Strazzer S, Del Bo R, Salani S, Bossolasco P, Fortunato F, et al. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp Cell Res. 2002;277:74-85.
20. Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med. 2003;9:1520-7.
21. Mutis T, Schrama E, Melief CJ, Goulmy E. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specifi c minor histocompatibility antigens and leukemia-associated antigens. Blood. 1998; 92:1677-84.
22. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purifi cation and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615-25.
23. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002;20:530-41.
24. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-4.
25. Imabayashi H, Mori T, Gojo S, Kiyono T, Sugiyama T, Irie R, et al. Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profi ling by largescale cDNA analysis. Exp Cell Res. 2003;288:35-50.
26. De Bari C, Dell A ccio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928-42.
27. Cossu G, Mavilio F. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J Clin Invest. 2000;105:1669-74.
28. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fi ber in response to injury. Cell. 2002;111:589-601.
29. Feng SW, Lu XL, Liu ZS, Zhang YN, Liu TY, Li JL, et al. Dynamic distribution of bone marrow-derived mesenchymal stromal cells and change of pathology after infusing into mdx mice. Cytotherapy. 2008;10:254-64.
30. Liu Y, Yan X, Sun Z, Chen B, Han Q, Li J, et al. Flk-1- adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev. 2007;16:695-706.
31. Li Z, Zhang C, Xie YM, Chen GJ, Liu XR. Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004; 26:294-7 [in Chinese].
32. Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, Goodyear LJ, et al. Highly effi cient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell. 2008;134:37-47.